These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 6340494)

  • 21. Impact of weight on long-term survival among patients without known coronary artery disease and a normal stress SPECT MPI.
    Uretsky S; Supariwala A; Singh P; Atluri P; Khokhar SS; Koppuravuri HK; Joshi R; Mandeva A; Rozanski A
    J Nucl Cardiol; 2010 Jun; 17(3):390-7. PubMed ID: 20300906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of body mass index on clinical outcome in patients with acute coronary syndromes treated with percutaneous coronary intervention.
    Ndrepepa G; Keta D; Byrne RA; Schulz S; Mehilli J; Seyfarth M; Schömig A; Kastrati A
    Heart Vessels; 2010 Jan; 25(1):27-34. PubMed ID: 20091395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neural mechanisms and management of obesity-related hypertension.
    Esler MD; Eikelis N; Lambert E; Straznicky N
    Curr Cardiol Rep; 2008 Nov; 10(6):456-63. PubMed ID: 18950554
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms underlying obesity associated with systemic and renal hemodynamics in essential hypertension.
    Frohlich ED; Susic D
    Curr Hypertens Rep; 2008 Apr; 10(2):151-5. PubMed ID: 18474183
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obesity and insulin resistance: effects on cardiac structure, function, and substrate metabolism.
    Peterson LR
    Curr Hypertens Rep; 2006 Dec; 8(6):451-6. PubMed ID: 17087855
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of isolated obesity on systolic and diastolic left ventricular function.
    Pascual M; Pascual DA; Soria F; Vicente T; Hernández AM; Tébar FJ; Valdés M
    Heart; 2003 Oct; 89(10):1152-6. PubMed ID: 12975404
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Obesity as a determinant for response to antihypertensive treatment.
    Schmieder RE; Gatzka C; Schächinger H; Schobel H; Rüddel H
    BMJ; 1993 Aug; 307(6903):537-40. PubMed ID: 8400973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interactions between insulin and norepinephrine on blood pressure and insulin sensitivity. Studies in lean and obese men.
    Baron AD; Brechtel G; Johnson A; Fineberg N; Henry DP; Steinberg HO
    J Clin Invest; 1994 Jun; 93(6):2453-62. PubMed ID: 8200981
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of hypertension in children.
    Sinaiko AR
    Pediatr Nephrol; 1994 Oct; 8(5):603-9. PubMed ID: 7819013
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The pathogenesis of hypertension in obese subjects.
    Weidmann P; de Courten M; Boehlen L; Shaw S
    Drugs; 1993; 46 Suppl 2():197-208; discussion 208-9. PubMed ID: 7512475
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cardiovascular pathophysiology of essential hypertension: a clue to therapy.
    Messerli FH; Ventura HO
    Drugs; 1985; 30 Suppl 1():25-34. PubMed ID: 2994985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Factors involved in the pathogenesis of hypertensive cardiovascular hypertrophy. A review.
    Dahlöf B
    Drugs; 1988; 35 Suppl 5():6-26. PubMed ID: 2975216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Left ventricular hypertrophy. A cardiovascular risk factor in essential hypertension.
    Messerli FH; Schmieder R
    Drugs; 1986; 31 Suppl 4():192-201. PubMed ID: 2942387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and hypertension in blacks.
    Dustan HP
    Cardiovasc Drugs Ther; 1990 Mar; 4 Suppl 2():395-402. PubMed ID: 2271401
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetics of intravenous bisoprolol in obese and non-obese volunteers.
    Le Jeunne C; Poirier JM; Cheymol G; Ertzbischoff O; Engel F; Hugues FC
    Eur J Clin Pharmacol; 1991; 41(2):171-4. PubMed ID: 1683835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disparate cardiovascular effects of obesity and arterial hypertension.
    Messerli FH; Sundgaard-Riise K; Reisin E; Dreslinski G; Dunn FG; Frohlich E
    Am J Med; 1983 May; 74(5):808-12. PubMed ID: 6340494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cardiovascular adaptation to obesity and hypertension.
    Lavie CJ; Messerli FH
    Chest; 1986 Aug; 90(2):275-9. PubMed ID: 2942341
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Does obesity influence early target organ damage in hypertensive patients?
    Schmieder RE; Messerli FH
    Circulation; 1993 May; 87(5):1482-8. PubMed ID: 8491003
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular effects of obesity and hypertension.
    Messerli FH
    Lancet; 1982 May; 1(8282):1165-8. PubMed ID: 6122945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity and essential hypertension. Hemodynamics, intravascular volume, sodium excretion, and plasma renin activity.
    Messerli FH; Christie B; DeCarvalho JG; Aristimuno GG; Suarez DH; Dreslinski GR; Frohlich ED
    Arch Intern Med; 1981 Jan; 141(1):81-5. PubMed ID: 7004372
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.